BEAM logo

Beam Therapeutics Inc.

BEAM
Healthcare|Biotechnology|US
$26.41
+0.54 (+2.09%)
Tangible Book / Share
$9.10
Cash / Share
$9.97

Clinical Trials (15)

TrialConditionsPhaseStatusEnrollmentDesignDrug
NCT05456880
BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease
Sickle Cell Disease
P1P2
Active15Open-labelBEAM-101
NCT06389877
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
Alpha 1-Antitrypsin Deficiency
P1P2
Recruiting192Open-labelBEAM-302
NCT05885464
A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)
Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma
P1P2
Active5Open-labelBEAM-201
NCT06735755
A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)
Glycogen Storage Disease Type Ia
P1P2
Recruiting36Open-labelBEAM-301: Single dose of BEAM-301 administered by IV
NCT06934382
Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
T-Cell Acute Lymphoblastic Leukemia/Lymphoma
P1
Recruiting33Open-labelAllogeneic anti-CD7 CAR-T cells (BEAM-201)
NCT07304791
This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects
Healthy Subjects, Healthy Participant Study
P1
Recruiting30RCT, Single-blindBEAM-103, Placebo Comparator
NCT07373639
A Long-term Follow-up Study in Patients Who Received BEAM-101
Hemoglobinopathy, Sickle Cell Disease
Recruiting50—Long-Term Follow-up Study of patients who received BEAM-101
NCT06071377
Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
Sickle Cell Trait
Recruiting1,000——
NCT07153094
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen)
Solid Tumor, Adult
N/A
Active47Open-label—
NCT07137195
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)
Solid Tumor, Adult
N/A
Active47Open-label—
NCT06397560
PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial
Glioma, Glioma, Malignant
N/A
Recruiting28Open-label—
NCT07152353
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Sichuan)
Solid Tumor, Adult
N/A
Active47Open-label—
NCT07910422
Intradiscal Ozone/Oxygen Injection for Treatment of Contained Lumbar Disc Herniation
Lumbar Disc Herniation
By Invite80——
NCT05521243
An Exploratory Investigation of a Supplement to Enhance Sleep Quality and Quantity
Sleep, Sleep Disturbance
N/A
Completed64RCT, Double-blind—
NCT07183735
A Crossover Trial to Examine the Efficacy of a Powder to Improve Sleep Quality and Performance
Sleep, Sleep Disorder
N/A
Completed40RCT, Double-blind—